الصفحة الرئيسية>>Signaling Pathways>> PROTAC>>HaloPROTAC 2

HaloPROTAC 2 (Synonyms: HaloPROTAC 2)

رقم الكتالوجGC32831

HaloPROTAC 2 (HaloPROTAC 2) عبارة عن اتحاد من الروابط للرابط E3 و 21 ذرة طولًا. موصل الرابط هو مجموعة هالوجين. يشتمل HaloPROTAC 2 على رابط VHL المستند إلى VH032 ورابط PEG المكون من 5 وحدات. HaloPROTAC 2 قادر على إحداث تدهور GFP-HaloTag7 في المقايسات القائمة على الخلية.

Products are for research use only. Not for human use. We do not sell to patients.

HaloPROTAC 2 التركيب الكيميائي

Cas No.: 1799506-06-1

الحجم السعر المخزون الكميّة
10mM (in 1mL DMSO)
496٫00
متوفر
5mg
346٫00
متوفر
10mg
576٫00
متوفر
25mg
1152٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

HaloPROTAC 2, a chloroalkane-containing PROTAC, induces degradation of HaloTag fusion proteins.

HaloPROTAC 1 and HaloPROTAC2, containing different linker lengths, are synthesized. Their ability to degrade GFP-HaloTag7, (stably expressed in HEK 293 cells) is tested tby flow cytometry, measuring changes in mean fluorescence intensity. While 24 hour treatment with HaloPROTAC 1 leads to less than 20% degradation, the longer HaloPROTAC2 leads to nearly 70% degradation of GFP-Halotag7 at 2.5 μM[1].

[1]. Buckley DL, et al. HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion Proteins. ACS Chem Biol. 2015 Aug 21;10(8):1831-7.

مراجعات

Review for HaloPROTAC 2

Average Rating: 5 ★★★★★ (Based on Reviews and 14 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for HaloPROTAC 2

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.